Pattern of perfusion defects seen in ischemic heart disease patients on technetium (Tc99m) tetrofosmin scanning

Abdul Rahman1, Jawed Aftab, Rehan Majeed

  • 1Department of Cardiology, Ziauddin Medical University, Karachi, Pakistan.

Insights

Technetium tetrofosmin (Tc99m) SPECT imaging identified ischemic changes in 35 patients with suspected heart disease. Reversible ischemia and mixed defects were most common in the inferior wall, while fixed defects appeared at the left ventricular apex.

Area of Science:

  • Nuclear Cardiology
  • Cardiovascular Imaging
  • Radiopharmaceuticals

Background:

  • Cardiovascular disease is a leading cause of mortality globally.
  • Atherosclerosis, or coronary artery narrowing, is the primary cause of ischemic heart disease.
  • Accurate detection of ischemic changes is crucial for patient management.

Purpose of the Study:

  • To determine the pattern of ischemic changes using technetium tetrofosmin (Tc99m) SPECT imaging.
  • To evaluate the diagnostic utility of Tc99m tetrofosmin in ischemic heart disease.
  • To analyze the distribution and types of perfusion defects.

Main Methods:

  • Sixty-five patients with known or suspected ischemic heart disease were included.
  • Tc99m tetrofosmin stress and rest myocardial perfusion imaging was performed.
  • A one-day protocol was utilized for the tetrofosmin studies.

Main Results:

  • SPECT Tc99m tetrofosmin imaging revealed perfusion defects in 35 out of 65 patients.
  • A total of 95 perfusion defects were analyzed.
  • Reversible and mixed ischemic defects were predominantly observed in the inferior wall.

Conclusions:

  • The inferior wall frequently exhibited reversible and mixed perfusion defects.
  • Fixed defects were most commonly identified in the left ventricular apex.
  • Tc99m tetrofosmin SPECT imaging effectively characterizes ischemic patterns in the heart.
Abstract

Related Concept Videos

Assessment of Diffusion and Perfusion01:17

Assessment of Diffusion and Perfusion

Understanding and evaluating diffusion and perfusion is critical in assessing a patient's respiratory and circulatory health. These processes play key roles in maintaining the body's internal environment, ensuring that tissues receive adequate oxygen while waste products are efficiently removed.
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this principle...
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...